NCT00193921 - Chemoradiotherapy in Patients With Localised Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2012

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG

Vinorelbine

IV, 25mg/m2, days 1, 8, 22

RADIATION

High dose Radiotherapy

External beam radiation, 40 Gy/20#/5 per week

DRUG

Gemcitabine

200mg (flat dose) IV days 1, 8, 15

DRUG

Cisplatin

20mg/m2, IV, weekly

RADIATION

High Dose Radiotherapy

External beam radiation, 30 Gy/15#/5 per week

Trial Locations (8)

2298

Calvary Mater Newcastle, Newcastle

4101

Mater Misericordiae Hospital, Brisbane

4102

Princess Alexandra Hospital, Brisbane

4224

The John Flynn Hospital, Tugun

4810

North Queensland Oncology Service, Townsville

8006

Peter MacCallum Cancer Centre, Melbourne

Unknown

Frankston Hospital, Frankston

Border Medical Oncology, Wondonga

All Listed Sponsors

collaborator

Cancer Council Queensland

OTHER

collaborator

Victorian Cancer Council

UNKNOWN

lead

Trans Tasman Radiation Oncology Group

OTHER